Jingbo Pi, a researcher at The Hamner Institutes for Health Sciences, has received a $415,000 grant for diabetes research.
The grant from the National Institutes of Health covers three years.
Pi is a research investigator in the Division of Translational Biology at the Hamner. He will study insulin secretion and how it is affected by so-called reactive oxygen species (Those species include superoxide, hydrogen peroxide, and hydroxyl radical.)
“Understanding cell signaling pathways and the conditions that affect them is critical in the development of new therapies,” said William Greenlee, chief executive officer of The Hamner. “This funding will allow for research of cell signaling pathways within the pancreas, an organ that has a major impact on human health and is linked to many diseases.”
Pi hopes to help develop new strategies for treating diabetes.
